PPAR agonists and the metabolic syndromeSTAELS, Bart.Thérapie (Paris). 2007, Vol 62, Num 4, pp 319-326, issn 0040-5957, 8 p.Conference Paper

Rev-erb-α: an integrator of circadian rhythms and metabolism : The Role of clock Genes in Cardiometabolic DiseaseDUEZ, Hélène; STAELS, Bart.Journal of applied physiology (1985). 2009, Vol 107, Num 6, pp 1972-1980, issn 8750-7587, 9 p.Article

The expanding role of the bile acid receptor FXR in the small intestineCARIOU, Bertrand; STAELS, Bart.Journal of hepatology. 2006, Vol 44, Num 6, pp 1213-1215, issn 0168-8278, 3 p.Article

Nuclear Receptors Linking Circadian Rhythms and Cardiometabolic Control : Nuclear receptors in metabolism and cardiovascular diseaseDUEZ, Hélène; STAELS, Bart.Arteriosclerosis, thrombosis, and vascular biology. 2010, Vol 30, Num 8, pp 1529-1534, issn 1079-5642, 6 p.Article

Rôle protecteur de la voie fibrates/p16^INK4A dans les lésions vasculaires occlusives = The fibrate-activated PPARα/p16^INK4A pathway inhibits vascular smooth muscle cell proliferation and vascular occlusionGIZARD, Florence; STAELS, Bart.MS. Médecine sciences. 2006, Vol 22, Num 4, pp 351-353, issn 0767-0974, 3 p.Article

Bile Acids and Metabolic Regulation: Mechanisms and clinical responses to bile acid sequestrationSTAELS, Bart; FONSECA, Vivian A.Diabetes care. 2009, Vol 32, Num 3, pp 5237-5245, issn 0149-5992, 9 p., SUPConference Paper

Bile acid sequestrants and the treatment of type 2 diabetes mellitusSTAELS, Bart; KUIPERS, Folkert.Drugs (Basel). 2007, Vol 67, Num 10, pp 1383-1392, issn 0012-6667, 10 p.Article

Effects of the New Dual PPARα/δ Agonist GFT505 on Lipid and Glucose Homeostasis in Abdominally Obese Patients With Combined Dyslipidemia or Impaired Glucose MetabolismCARIOU, Bertrand; ZAÏR, Yassine; STAELS, Bart et al.Diabetes care. 2011, Vol 34, Num 9, pp 2008-2014, issn 0149-5992, 7 p.Article

Retinoid X receptors: common heterodimerization partners with distinct functionsLEFEBVRE, Philippe; BENOMAR, Yacir; STAELS, Bart et al.Trends in endocrinology and metabolism. 2010, Vol 21, Num 11, pp 676-683, issn 1043-2760, 8 p.Article

Regulation of Macrophage Functions by PPAR-α, PPAR-γ, and LXRs in Mice and MenRIGAMONTI, Elena; CHINETTI-GBAGUIDI, Giulia; STAELS, Bart et al.Arteriosclerosis, thrombosis, and vascular biology. 2008, Vol 28, Num 6, pp 1050-1059, issn 1079-5642, 10 p.Article

Systemic and Distal Repercussions of Liver-Specific Peroxisome Proliferator-Activated Receptor-α Control of the Acute-Phase ResponseMANSOURI, Roxane M; BAUGE, Eric; STAELS, Bart et al.Endocrinology (Philadelphia). 2008, Vol 149, Num 6, pp 3215-3223, issn 0013-7227, 9 p.Article

The glucocorticoid receptor is a co-regulator of the orphan nuclear receptor Nurr1CARPENTIER, Rodolphe; SACCHETTI, Paola; SEGARD, Pascaline et al.Journal of neurochemistry. 2008, Vol 104, Num 3, pp 777-789, issn 0022-3042, 13 p.Article

Un rôle pour PPARγ dans la reproduction ? = A role of PPARγ in reproduction ?FROMENT, Pascal; GIZARD, Florence; STAELS, Bart et al.MS. Médecine sciences. 2005, Vol 21, Num 5, pp 507-511, issn 0767-0974, 5 p.Article

Les peroxisome proliferator-activated receptors: des récepteurs nucléaires au carrefour entre métabolisme lipidique et inflammation = Peroxisome proliferator-activated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammationBOCHER, Virginie; CHINETTI, Giulia; FRUCHART, Jean-Charles et al.STV. Sang thrombose vaisseaux. 2001, Vol 13, Num 2, pp 82-88, issn 0999-7385Article

Peroxisome proliferator-activated receptors and atherogenesis: Regulators of gene expression in vascular cellsMARX, Nikolaus; DUEZ, Hélène; FRUCHART, Jean-Charles et al.Circulation research. 2004, Vol 94, Num 9, pp 1168-1178, issn 0009-7330, 11 p.Article

Rôles des Peroxisome Proliferator-Activated Receptors (PPARs) dans la régulation du métabolisme des lipides et le contrôle de l'inflammation : Les Cytokines : de la Clinique à la Biologie ? = Roles of the Peroxisome Proliferator-Activated Receptors (PPARs) in the regulation of lipid metabolism and inflammation control : Cytokines: from clinic to biology?BOCHER, Virginie; CHINETTI, Giulia; FRUCHART, Jean-Charles et al.Journal de la Société de biologie. 2002, Vol 196, Num 1, pp 47-52, issn 1295-0661Conference Paper

Glitazones in the treatment of cardiovascular risk factorsBOUHLEL, Mohamed Amine; CHINETTI-GBAGUIDI, Giulia; STAELS, Bart et al.Fundamental & clinical pharmacology. 2007, Vol 21, pp 7-13, issn 0767-3981, 7 p., SUP2Conference Paper

Rosiglitazone, a peroxisome proliferator-activated receptor-γ, inhibits the Jun NH₂-Terminal kinase/activating protein 1 pathway and protects the heart from ischemia/reperfusion injuryKHANDOUDI, Nassirah; DELERIVE, Philippe; BERREBI-BERTRAND, Isabelle et al.Diabetes (New York, NY). 2002, Vol 51, Num 5, pp 1507-1514, issn 0012-1797Article

PPAR (peroxisome proliferator-activated receptors) et paroi vasculaire : implications dans l'athérosclérose = Peroxisome proliferator-activated receptors in human atherosclerosisLESTAVEL, Sophic; CHINETTI, Giulia; BOCHER, Virginie et al.MS. Médecine sciences. 2001, Vol 17, Num 5, pp 637-642, issn 0767-0974Article

Rôle des PPARs dans la régulation du métabolisme des lipoprotéines et de l'athéroscléroseBLANQUART, Christophe; FRUCHART, Jear Charles; STAELS, Bart et al.MTE. Médecine thérapeutique endocrinologie. 2001, Vol 3, Num OCT, pp 26-32, issn 1295-9359, NS2Article

Fenofibrate, a peroxisome proliferator-activated receptor-a agonist, exerts anticonvulsive propertiesPORTA, Natacha; VALLEE, Louis; LECOINTE, Cécile et al.Epilepsia (Copenhagen). 2009, Vol 50, Num 4, pp 943-948, issn 0013-9580, 6 p.Article

Modulation of hepatic inflammatory risk markers of cardiovascular diseases by PPAR-α activators : Clinical and experimental evidenceZAMBON, Alberto; GERVOIS, Philippe; PAULETTO, Paolo et al.Arteriosclerosis, thrombosis, and vascular biology. 2006, Vol 26, Num 5, pp 977-986, issn 1079-5642, 10 p.Article

Characterization of new PPARγ agonists: Benzimidazole derivatives—importance of positions 5 and 6, and computational studies on the binding modeGOEBEL, Matthias; WOLBER, Gerhard; MARKT, Patrick et al.Bioorganic & medicinal chemistry. 2010, Vol 18, Num 16, pp 5885-5895, issn 0968-0896, 11 p.Article

Role of the peroxisome proliferator-activated receptors (PPAR) in atherosclerosisNEVE, Bernadette P; FRUCHART, Jean-Charles; STAELS, Bart et al.Biochemical pharmacology. 2000, Vol 60, Num 8, pp 1245-1250, issn 0006-2952Conference Paper

PPARα activation differently affects microparticle content in atherosclerotic lesions and liver of a mouse model of atherosclerosis and NASHBARON, Morgane; LEROYER, Aurélie S; TAILLEUX, Anne et al.Atherosclerosis. 2011, Vol 218, Num 1, pp 69-76, issn 0021-9150, 8 p.Article